BAY 1895344 is a potent, highly selective and orally available ATR inhibitor.

Daunorubicin Hydrochloride is the hydrochloride salt of an anthracycline antineoplastic antibiotic with therapeutic effects similar to those of doxorubicin.

Vorambucil is a DNA/HDAC dual-targeting inhibitor.

Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV.

Temozolomide is a triazene analog of dacarbazine with antineoplastic activity.

Norfloxacin is a synthetic fluoroquinolone with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria

Irinotecan, a prodrug, is converted to a biologically active metabolite SN-38 by a carboxylesterase-converting enzyme.

Veliparib is a potent inhibitor of PARP1 and PARP2. It is inactive to SIRT2.